Navigation Links
Janssen Therapeutics Announces Recipient of Its Second Point Scholarship for LGBT Students
Date:7/16/2013

TITUSVILLE, N.J., July 16, 2013 /PRNewswire/ -- Janssen Therapeutics, Division of Janssen Products, LP (Janssen) announced today the recipient of the second scholarship the company is supporting through the Point Foundation, the nation's largest scholarship-granting organization for lesbian, gay, bisexual and transgender (LGBT) students of merit. Janssen is the first pharmaceutical company to fund a Point Scholarship.  

The Point Scholarship supported by Janssen is for LGBT students whose field of study is focused on HIV/AIDS, or who have chosen to attend business school. It has been awarded to Michael Haymer of Orange County, California. Michael is pursuing a joint MD-MBA degree from the PRIME Program at the David Geffen School of Medicine at University of California, Los Angeles (UCLA).

The Point Scholarship is granted for a four-year period to graduating high school seniors and college students. As a Point Scholar, Michael will receive financial assistance and will be matched with a successful professional who can serve as his mentor and role model.

Michael and his four siblings were raised by their single mother who died from complications of undertreated diabetes during his first year of medical school. As a tribute to her, Michael focused his studies on serving under-resourced and vulnerable populations. 

"I'm personally committed to my research and work as a community educator in the areas of LGBT and HIV health because I know firsthand how important it is to give a voice to underserved populations," said Michael. "With this scholarship, I look forward to setting an example for other LGBT students interested in healthcare and continuing the tradition of Point Scholars."

Michael has a particular interest in the area of transgender healthcare. He directed the LGBT Health Student Symposium, which hosted more than 100 students f
'/>"/>

SOURCE Janssen Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Second Genome Announces Agreement with Janssen on Microbiome Drug Discovery in Ulcerative Colitis
2. Primary Efficacy and Safety Findings from Phase 3 Study of Janssens Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients
3. Janssen and Johnson & Johnson to Provide Webcast Presentation of Simeprevir Phase 3 Clinical Data Presented at The International Liver Congress of the European Association for the Study of the Liver (EASL)
4. Findings from Two Phase 3 Studies of Janssens Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Genotype 1 Chronic Hepatitis C Patients
5. Janssen Submits New Drug Application to U.S. FDA for Simeprevir (TMC435) for Combination Treatment of Adult Patients with Genotype 1 Chronic Hepatitis C
6. Janssen Launches EXPLORER, Global Cardiovascular Research Program, Beginning with Five New Studies in Patients with Unmet Medical Needs
7. Janssen Pharmaceutica, NV, Funds New Global Mental Health Scholarships as Part of Its Healthy Minds Program
8. Janssen Neuroscientists and Colleagues Challenge Healthcare Industry to Create Integrated Approaches to Healthcare Innovation in Newly Published Article
9. Janssen Labs at San Diego Expands to Add Concept Lab and Open Collaboration Space to Accommodate Individual Entrepreneurs and Additional Life Science Start-Ups
10. Janssen Research & Development Submits New Drug Application to U.S. FDA for Canagliflozin/Metformin Fixed-Dose Combination Therapy to Treat Patients with Type 2 Diabetes
11. Janssen Research & Development Announces Establishment of Global Cross-Pharmaceutical Clinical Trial Investigator Databank
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... 2014   Ventana Medical Systems, Inc.  (Ventana), a ... entered into an agreement with Merck KGaA, Darmstadt, ... in the United States and ... KGaA,s biopharmaceutical division on the development and commercialization of ... Ventana,s proprietary diagnostic assays. In alignment with Merck KGaA,s ...
(Date:1/15/2014)... Sono-Tek Corporation (OTC BB: SOTK) today announced sales of  ... to sales of $2,202,000 for the prior year period, an ... also shown growth over the preceding quarter,s sales, continuing a ... year. Markets that experienced sales increases over the prior year ...
(Date:1/15/2014)... Foundation today announced it has established a relief fund ... weather that has gripped much of the nation. AARP and ... to support these emergency relief efforts AARP and AARP Foundation ... up to $500,000 in aid. The matching program will be ...
Breaking Medicine Technology:Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 3Sono-Tek Announces Third Quarter Results 2Sono-Tek Announces Third Quarter Results 3Sono-Tek Announces Third Quarter Results 4AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3
(Date:7/12/2014)... Wright & Schulte LLC, an experienced law firm ... Lawsuits (case #59776/2014), announces they have launched a new ... the popular hair dye, Just For Men, has caused some ... and other areas. In addition to detailing symptoms that are ... the advertisements being run by Wright & Schulte LLC will ...
(Date:7/12/2014)... Beach, FL (PRWEB) July 12, 2014 ... of high-quality peptides that are used solely in scientific ... honor two successful years in business, Maxim Peptide, which ... has just launched a new and updated website that ... research blog section has been updated with fascinating articles ...
(Date:7/11/2014)... Recently, MagicQuinceaneraDresses.com, the popular online supplier of ... 2014 Quinceanera dresses . The company’s new items ... fashionable without paying a large amount of money. They ... off. , The company’s online shop has become a ... occasion outfits. In addition to exquisite Quinceanera dresses, it ...
(Date:7/11/2014)... 12, 2014 According to new ... market is expected to register a CAGR of ... Browse 71 market data tables and 76 figures ... "C4ISR Market"., http://www.marketsandmarkets.com/Market-Reports/c4isr-market-1315.html , Early buyers ... http://www.marketsandmarkets.com/requestCustomization.asp?id=1315 , The report provides market analysis ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 Butler Mobility has ... Inclined Platform Lifts . Previously the two standard ... five new beautiful earth tone colors as standard colors at ... well in the home but will enhance the beauty of ... for any home color scheme or individual décor. , The ...
Breaking Medicine News(10 mins):Health News:Just for Men Lawsuit News: TV Campaign Launched by Wright & Schulte LLC to Inform Consumers of the Alleged Association between the Popular Hair Dye and Chemical Burns 2Health News:Just for Men Lawsuit News: TV Campaign Launched by Wright & Schulte LLC to Inform Consumers of the Alleged Association between the Popular Hair Dye and Chemical Burns 3Health News:Just for Men Lawsuit News: TV Campaign Launched by Wright & Schulte LLC to Inform Consumers of the Alleged Association between the Popular Hair Dye and Chemical Burns 4Health News:Maxim Peptide Celebrates Second Anniversary Online with an Updated Website and Special Deals Section 2Health News:Cheap Quinceanera Dresses Now Available At MagicQuinceaneraDresses.com 2Health News:C4ISR Market Estimated to Reach $93.04 Billion by 2019 - New Report by MarketsandMarkets 2Health News:C4ISR Market Estimated to Reach $93.04 Billion by 2019 - New Report by MarketsandMarkets 3Health News:C4ISR Market Estimated to Reach $93.04 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Butler Mobility Products Announces Five New Standard Colors for Their Inclined Platform Lifts 2
... commonly prescribed cholesterol-lowering drug ezetimibe (Zetia) is so potent. ... University School of Medicine, is reported online today by ... the July 2 print issue. ,It had ... cells in the intestine from absorbing cholesterol. The new ...
... Louis researchers have identified common DNA variations that ... of the eight genetic alterations the scientists identified ... vaccination. A few, however, reduced fever risk. ... same genetic variations linked to fever following smallpox ...
... to scientist at annual conference of the European Society ... abnormal can undergo chromosomal modifications. , ... Maternity Hospital, Tel Aviv Sourasky Medical Centre, Tel Aviv, ... meant that the results of preimplantation genetic screening (PGS) ...
... For many decades, medical research studies focused primarily on ... applied to women. But we now know that the ... women are more than skin deep. Beginning in 1990, ... based advocacy organization, conveyed to a national audience the ...
... and their friends filled the area in and around the ... 14th annual Komen Puget Sound Race for the Cure . ... cancer, while many others were running to honor family members ... in the pink T-shirts and sporting the medallions awarded by ...
... much as $2.7 billion a year, according to the Access ... of Crohn's disease and ulcerative colitis. Crohn's disease is a ... ulcerations (breaks in the lining) of the small and large ... mouth to the anus. It is named after the physician ...
Cached Medicine News:Health News:Animal Research Uncovers Another Mechanism of Cholesterol Lowering Drug 2Health News:Genetic Variations Leads to Fever After Smallpox Vaccination 2Health News:Genetic Variations Leads to Fever After Smallpox Vaccination 3Health News:Preimplanted Genetic Screening Should Be Interpreted With Caution 2Health News:Rare Womens Lung Disease May Yield Insights Into Common Diseases 2Health News:Annual Cancer Run Draws Huge Response in US 2Health News:Inflamed Intestines Cost Australians Heavily 2
The FastPack system is a state of the art, lab quality immunoassay system designed for rapid results. The FastPack system delivers lab-quality sensitivity at a fraction of the cost of laboratory....
... When you need quick, accurate, convenient, and ... compact VITROS DT60 II Chemistry System. This ... and back-up laboratory testing requirements. And it ... -- better patient outcomes, reduced overall costs, ...
... In an effort to improve on ... hormones, toxicology, abused drugs, and immunosuppressants ... 1991 which incorporates random access capabilities. ... has undergone several important changes in ...
AxSYM Plus provides cutting-edge ergonomics and smart new features that mean increased ease-of-use and enhanced reliability. Also, advanced software means less operator intervention and high-integrit...
Medicine Products: